{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Institut Pasteur", "item": "https://www.patentleaderboard.com/2021/company/institut-pasteur"}, {"@type": "ListItem", "position": 4, "name": "Pierre ROCHETEAU", "item": "https://www.patentleaderboard.com/2021/inventor/fl:pi_ln:rocheteau-1"}]}

Home › 2021 › Institut Pasteur › Pierre ROCHETEAU

Pierre ROCHETEAU — 1 Patent in 2021

IPInstitut Pasteur: 1 patents #11 of 85Top 15%

UDUniversite De Paris Descartes: 1 patents #1 of 37Top 3%

Paris, FR: #276 of 1,196 inventorsTop 25%

Overall (2021): #300,214 of 548,734Top 55%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11013830	5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential	Fabrice Chretien, Raphael GAILLARD	2021-05-25

Pierre ROCHETEAU — 1 Patent in 2021

Issued Patents 2021

Patent Widget